There might even be an impact of [68Ga]Ga-PSMA-11 PET/CT on radiotherapeutic concepts for patients with primary prostate cancer [19,20,21], whereas a major focus of PSMA-11-related research has been reported in the field of recurrent prostate cancer. Here, FOLH1 is linked to prostate cancer.